Rita Ficarelli
Overview
Explore the profile of Rita Ficarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballatore Z, Merloni F, Ranallo N, Bastianelli L, Vitarelli F, Cantini L, et al.
Psychooncology
. 2021 Jul;
31(1):39-45.
PMID: 34315188
Objective: The coronavirus disease 2019 (COVID-19) outbreak has been declared a global pandemic of unprecedented proportions. Italy is a country which has been heavily affected. Cancer patients are at a...
2.
Graziano F, Ruzzo A, Canestrari E, Catalano V, Santini D, Galluccio N, et al.
Pharmacogenomics
. 2010 Sep;
11(9):1247-56.
PMID: 20860465
Aim: IGF binding protein-3 (IGFBP-3) displays growth inhibitory/proapoptotic action and counteracts the IGF-1 tumor-promoting effects by downregulating its bioavailability. We investigated whether IGFBP-3 SNPs determining high IGFBP-3 circulating levels are...
3.
Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D, et al.
Clin Chem Lab Med
. 2007 Jul;
45(7):822-8.
PMID: 17617021
Background: Gastric cancer is the second highest cause of cancer mortality in the world, despite declining rates of incidence in many industrialized countries. We carried out a case-control study to...
4.
Ruzzo A, Graziano F, Loupakis F, Rulli E, Canestrari E, Santini D, et al.
J Clin Oncol
. 2007 Apr;
25(10):1247-54.
PMID: 17401013
Purpose: The objective is to investigate whether polymorphisms with putative influence on fluorouracil/oxaliplatin activity are associated with clinical outcomes of patients with advanced colorectal cancer treated with first-line oxaliplatin, folinic...
5.
Ruzzo A, Graziano F, Kawakami K, Watanabe G, Santini D, Catalano V, et al.
J Clin Oncol
. 2006 Apr;
24(12):1883-91.
PMID: 16622263
Purpose: To investigate whether polymorphisms with putative influence on fluorouracil/cisplatin activity are associated with clinical outcomes of patients with advanced gastric cancer (AGC). Patients And Methods: Peripheral blood samples from...
6.
Graziano F, Ruzzo A, Santini D, Humar B, Tonini G, Catalano V, et al.
J Clin Oncol
. 2005 Apr;
23(10):2339-45.
PMID: 15800325
Purpose: A high interleukin-1beta (IL-1B) and interleukin-1 receptor antagonist (IL-RN) ratio underlies an unfavorable proinflammatory status. Also, it seems to be involved in the mechanisms of cancer cachexia and tumor...
7.
Graziano F, Kawakami K, Watanabe G, Ruzzo A, Humar B, Santini D, et al.
Int J Cancer
. 2004 Sep;
112(6):1010-4.
PMID: 15386366
We investigated in a case-control study a possible role of thymidylate synthase gene (TS) polymorphisms for gastric cancer susceptibility. Lymphocyte genomic DNA from 134 Italian gastric cancer patients and 139...